Innostars Awards Winner
Ligence has won the Innostars Awards hosted by the European Institute of Innovation and Technology. Ligence is a small startup company with a great idea and a heroic goal that will bring innovative solutions in healthcare.
Lithuanian Startup Museum
Ligence has been chosen to be displayed at the first in the world and first in Lithuania Startup Museum. The initiative is curated by Go Vilnius an agency for tourism and business development in Vilnius city
Echocardiography for COVID-19 Patients
Heart ultrasound might be extremely important to patients tested positive for COVID-19. The disease itself shows very complex pathophysiological mechanisms and may cause a variety of illnesses. Therefore, the examination can benefit patient outcomes in terms of survival and recovery from the disease.
Privacy policy updated
We have recently updated our website’s
Debunking AI. How can it help in clinical setting?
There is so much hype on the AI in the social media that we thought there must be some clarification to it. We will help you explain why any new medical technology must be taken cautiously.
On our way to Toronto
Our CEO will participate in the programme with the intention to understand Canadian market better and broaden our network.
Ligence granted development of CardioEchoAI
Lithuanian Business Support Agency (LVPA) has decided to fund development of CardioEchoAI – the tool for 2D transhoracic echocardiography automation.
Ligence receives grant to help fight COVID-19
Ligence has received the funding grant from MITA – Lithuanian Agency for Science, Technology and Innovation to help fight COVID-19.
COVID-19 presents with Pulmonary Embolism
Recent article published in JACC describes a case study of a female who developed Acute Pulmonary Embolism after being tested postive for COVID-19.
Case of a COVID-19 female presented with pericardial effusion
A case report published in JACC described a female who presented into a hospital with progressive shortness of breath. X-ray scan was inconclusive and therefore a heart ultrasound examination was performed. It showed a collection of blood within the pericardial cavity (called pericardial hemorrhagic effusion). The pathology later progressed into Takotsubo cardiomyopathy (also known as “broken heart disease”).